NEW YORK (GenomeWeb) – NxGen MDx said today its genetic screening and noninvasive prenatal testing will be available to Aetna's members as an in-network benefit, starting Feb. 15. 

The decision by Aetna follows a review of NxGen's products' features, such as full-gene sequencing. The health plan is the third-largest in the US with more than 46 million members. It will cover NxGen MDx's testing at a national level. 

NxGen MDx offers testing for up to 120 various genetic disorders. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.